Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 376 participants.
Also called NCT05544864
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 376 participants
- Registry
-
NCT05544864
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT05544864. Randomized; no masking; primary purpose treatment. Start 2022-09-28 (actual); primary completion 2026-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
- Acronym
- ISAR-DESIRE5
- Condition
- Coronary Artery Disease
- Condition
- Restenoses, Coronary
- Intervention (Device)
- Drug eluting stent (DES)
- Intervention (Device)
- Drug coated ballloon (DCB)
- Lead sponsor
- Deutsches Herzzentrum Muenchen
- Collaborator
- EvidentIQ Germany GmbH
- Collaborator
- Abbott
- Collaborator
- Technical University of Munich
Record details
- Record id
cardio:ct-nct05544864- Content hash
72b373242bdd3faa39c62ffe2c5b5bad2593649214d5b29318835b1fd0a7ea58